Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.23.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   41,736,950    
Beginning balance at Dec. 31, 2021 $ 112,550 $ 417 $ 342,765 $ (230,632)
Increase (Decrease) in Stockholders' Equity        
Net loss (19,215)     (19,215)
Stock-based compensation 7,588   7,588  
Issuance of restricted and performance stock units (in shares)   259,341    
Issuance of restricted and performance stock units 0 $ 2 (2)  
Exercise of stock options and employee stock purchase plan (in shares)   138,213    
Exercise of stock options and employee stock purchase plan 767 $ 1 766  
Ending balance (in shares) at Jun. 30, 2022   42,134,504    
Ending balance at Jun. 30, 2022 101,690 $ 420 351,117 (249,847)
Beginning balance (in shares) at Mar. 31, 2022   41,972,987    
Beginning balance at Mar. 31, 2022 103,851 $ 420 345,538 (242,107)
Increase (Decrease) in Stockholders' Equity        
Net loss (7,740)     (7,740)
Stock-based compensation 4,910   4,910  
Issuance of restricted and performance stock units (in shares)   44,054    
Exercise of stock options and employee stock purchase plan (in shares)   117,463    
Exercise of stock options and employee stock purchase plan 669   669  
Ending balance (in shares) at Jun. 30, 2022   42,134,504    
Ending balance at Jun. 30, 2022 $ 101,690 $ 420 351,117 (249,847)
Beginning balance (in shares) at Dec. 31, 2022 42,445,517 42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 360,155 (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (13,734)      
Stock-based compensation 8,344   8,344  
Issuance of restricted and performance stock units (in shares)   296,378    
Issuance of restricted and performance stock units 0 $ 4 (4)  
Exercise of stock options and employee stock purchase plan (in shares)   237,646    
Exercise of stock options and employee stock purchase plan $ 1,543 $ 2 1,541  
Ending balance (in shares) at Jun. 30, 2023 42,979,541 42,979,541    
Ending balance at Jun. 30, 2023 $ 97,152 $ 430 370,036 (273,314)
Beginning balance (in shares) at Mar. 31, 2023   42,809,994    
Beginning balance at Mar. 31, 2023 97,513 $ 428 363,739 (266,654)
Increase (Decrease) in Stockholders' Equity        
Net loss (6,660)      
Stock-based compensation 5,390   5,390  
Issuance of restricted and performance stock units (in shares)   57,659    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   111,888    
Exercise of stock options and employee stock purchase plan $ 909 $ 1 908  
Ending balance (in shares) at Jun. 30, 2023 42,979,541 42,979,541    
Ending balance at Jun. 30, 2023 $ 97,152 $ 430 $ 370,036 $ (273,314)